EX-99.1 2 a19-21464_1ex99d1.htm EX-99.1

Exhibit 99.1

 

LANNETT COMPANY, INC.

NET SALES BY MEDICAL INDICATION

 

 

 

Three months ended

 

Twelve months ended

 

($ in thousands)

 

September 30, 2018

 

December 31, 2018

 

March 31, 2019

 

June 30, 2019

 

June 30, 2019

 

Medical Indication

 

 

 

 

 

 

 

 

 

 

 

Analgesic

 

$

1,829

 

$

2,547

 

$

946

 

$

2,929

 

$

8,251

 

Anti-Psychosis

 

10,889

 

14,036

 

20,616

 

27,912

 

73,453

 

Cardiovascular

 

21,770

 

25,680

 

22,783

 

31,234

 

101,467

 

Central Nervous System

 

14,286

 

7,373

 

15,906

 

21,454

 

59,019

 

Endocrinology

 

53,878

 

88,477

 

55,210

 

(43

)

197,522

 

Gastrointestinal

 

17,594

 

12,943

 

16,501

 

16,005

 

63,043

 

Infectious Disease

 

4,480

 

4,616

 

4,162

 

3,692

 

16,950

 

Migraine

 

9,737

 

12,551

 

9,846

 

9,458

 

41,592

 

Respiratory/Allergy/Cough/Cold

 

3,584

 

3,388

 

2,549

 

2,958

 

12,479

 

Urinary

 

1,541

 

1,596

 

2,096

 

1,522

 

6,755

 

Other

 

10,805

 

12,606

 

14,247

 

13,859

 

51,517

 

Contract manufacturing revenue

 

4,661

 

7,905

 

7,932

 

2,861

 

23,359

 

Net Sales

 

$

155,054

 

$

193,718

 

$

172,794

 

$

133,841

 

$

655,407